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Abstract 
OBJECTIVE: Obesity related atherosclerosis is a systemic disease with a background 
connected to multiple metabolic-neurohumoral pathways. The leptin/adiponectin ratio (L/A 
ratio) has been suggested as an atherosclerotic marker in obese patients. The aim of the study 
was to assess: a) the significance of the L/A ratio in overweight subjects; b) the relation with 
anthropometric/metabolic parameters; c) gender difference.  
METHOD: The study included 80 adult male and female, overweight, non-diabetic patients. 
Biochemical blood analysis, anthropometric and cardiovascular measurements were 
performed. Serum leptin levels were measured with a RIA test and total adiponectin levels  
with ELISA. L/A ratios were calculated as ratios between total serum concentrations of leptin 
and adiponectin. 
RESULTS: Differences between leptin, adiponectin serum levels and L/A ratios are presented 
in overweight persons, where females have a significantly higher L/A ratio than men 
(p<0.001).  In men, the L/A ratio showed a positive correlation with total cholesterol levels 
(p=0.011), LDL (p=0.013) and triglycerides (p=0.032). In females, the L/A ratio correlated 
with anthropometric parameters of visceral obesity: waist circumference (p=0.001) and waist-
to-hip ratio (p=0.025).  
CONCLUSION: The L/A ratio could represent an atherosclerotic risk marker of the early 
stage of obesity. Gender plays a significant role in pathophysiological changes, with different 
clinical manifestations, where sex hormones have a crucial effect on neurohumoral adipose 
tissue activity. 
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Introduction: 
Obesity related atherosclerosis is caused by multiple metabolic changes that result in 
acute and chronic cardio-cerebro-vascular diseases, whereby inflammation and endothelial 
dysfunction play a key role (1-3).  The metabolic profile is associated with the presence of 
dyslipidemia, diabetes mellitus and hypertension, along with neurohumoral mechanisms 
caused by adipokines disbalance and cytokines activation. These factors, both individually 
and combined, have a great proatherogenic potential and each patient's atherosclerotic risk 
profile is unique (1). 
Adult obesity is characterised by adipocyte hypertrophy. More leptin and less 
adiponectin is secreted, whereby leptin could accelerate and adiponectin restrain the 
development of atherosclerosis (4) acting directly on vascular cells (5), which makes them 
important mediators linking adiposity and atherosclerosis in the adipo-vascular axis (5).  Both 
leptin and adiponectin could be individually associated with the development of 
atherosclerosis via plaque formation and progression and plaque rupture and thrombosis (2,3), 
and their combination might result in more atherosclerotic manifestations than their individual 
activity (6). The L/A ratio is a new surrogate marker for atherosclerosis in subjects with 
obesity and type 2 diabetes mellitus (4,6). It is a better parameter in monitoring for metabolic 
disorders (7)  such as: a) atherosclerotic index in patients with diabetes type 2 regardless of 
body weight and obesity level (4,7); b) parameter for insulin resistance (7); c) screening for 
vascular risk and endothelial dysfunction (8,9).  
From the clinical point of view, obesity related atherosclerosis is characterized by: 
insulin resistance, higher visceral fat, dyslipidemia, where a high L/A ratio and higher 
triglyceride serum levels may be additional obesity risk factors regardless of waist 
circumference and body mass index (10). Considering the relation between L/A ratio and an 
index of atherosclerosis in obese subjects with diabetes, the aim of this study was to examine 
the value of L/A ratio in overweight patients without diabetes, along with the other 
components of the metabolic syndrome, and to determine whether there are gender-based 
differences. 
 
Materials and methods 
 The study included 80 adult, hypertensive, overweight subjects (BMI 25-29.99kg/m2), 
who were hospitalized at the Department for Cardiovascular Disease, University Hospital 
Osijek because of myocardial infarction. All involved subjects voluntarily agreed to 
participate in the study and gave their written consent. The study was authorized by the 
hospital Ethics Committee. 
Inclusion criteria for this study were: adult overweight subjects of both sexes, no 
diabetes mellitus, normal renal function. Included females were postmenopausal and were not 
taking hormonal replacement therapy. Other presented conventional risk factors were 
hypertension, dyslipidemia and smoking. Exclusion criteria for the study were: glucose 
intolerance and diabetes, renal failure, BMI above 30 kg/m2 or less than 25 kg/m2, systolic 
dysfunction (EF LV<55%), history of previous myocardial infarctions and/or acute stroke. 
Medical history, physical examination, biochemical and anthropometric 
measurements, monitored values of blood pressure, transthoracic echocardiography and 
coronary angiography by a standard procedure were performed in all patients.  
Leptin and adiponectin blood samples were taken from all subjects in the morning, at 
the same time. Serum leptin levels were measured using the RIA-CT method and total 
circulating adiponectin serum levels were measured using ELISA for quantitative 
determination of human adiponectin, Biosource Europe S.A, Belgium. L/A ratio was 
calculated as the ratio between total serum concentrations of leptin and adiponectin.  
 
Statistical analysis 
All statistical tests were two-sided and carried out to a significance level (P) of 0.05. 
Distribution normality for leptin/adiponectin level was tested using Shapiro-Wilks test. 
According to results of the Shapiro-Wilks test, the nonparametric Mann-Whitney test was 
used. To verify relationship between univariate relations, we used the Spearman method. Data 
was prepared for analysis in Microsoft Excel 2003. Statistical analysis was done by SPSS 
15.0 for Windows Evaluation Version and Statistica 7.1. 
 
Results  
Subjects in both groups were Caucasian, overweight, with conventional risk factors, 
normal renal function and no other significant co-morbidities. The average age in the group of 
male subjects was 59.47±7.60 years while it was 64.10±7.59 years in female subjects.  
According to the results, leptin and adiponectin levels varied in males and females 
(11,12). Leptin levels were statistically significantly higher in females compared to the male 
group (p<0.001); also total adiponectin levels were higher in the female group than in the 
male group (p=0.006). According to these results, the L/A ratio showed a gender-related 
difference, where the L/A ratio is lower in men than in women p<0.001 (Figure1). 
Statistically significant correlation was found between the L/A ratio and metabolic parameters 
in male subjects (total cholesterol p=0.011, triglycerides p=0.032, LDL p=0.013), but there 
was no significant correlation with glucose level in this sample size. The results suggest that 
correlation might be positive in a study with a larger sample. In females, the L/A ratio 
significantly correlated with anthropometric parameters (waist circumference p=0.001, waist-
to-hip ratio p=0.025). In both groups of patients, the L/A ratio did not correlate with weight in 
both genders (male p=0.380, female p=0.350) or with BMI (male p=0.091, female p=0.080). 
 
Discussion 
 Visceral type of obesity is an independent risk factor for atherosclerosis, but the 
personal profile is unique as a result of the complexity of included metabolic, genetic and 
environmental risk factors and influences. Neurohumoral mechanisms that link 
atherosclerosis with obesity are: adipocytokines production, endothelial dysfunction and 
chronic inflammation. Regarding opposite effect of leptin and adiponectin on vascular 
endothelium, angiogenesis, inflammatory and thrombogenic state in obesity, it is logical is to 
consider the L/A ratio as a possible marker for atherosclerosis.  
There are still unanswered questions: can the L/A ratio serve as an early 
atherosclerotic marker in the pre-stage of obesity or in patients without diabetes mellitus? 
What is the clinical relevance of the L/A ratio and is there a gender-related difference?  Data 
in this area are very scarce, especially if one takes into account differences based on race and 
ethnicity.   
 Results from our study confirm the significance of gender differences of the L/A ratio 
and its correlation with anthropometric and metabolic profiles. The L/A ratio is not related 
with BMI or weight measurements, but in females it is related with visceral type of obesity, 
while this is not evident in males in this early stage of obesity. This is probably caused by 
hormone-related differences in body structure and distribution of adipose tissue in men and 
women, especially in overweight persons since it is not clear if significant changes in 
synthetic activity of adipose tissue start at this obesity level (4). It is possible that visceral 
obesity is manifested earlier in women than in men at lower levels of obesity. Also, in early 
stages of obesity, adipose tissue is less active as a possible consequence of low-grade 
adipokines inflammation (7,8).    
On the other hand, the L/A ratio correlates with lipidogram components in men, while there is 
no correlation in women at this level of obesity. The reason for this might be a still 
unexplained activity of fat cells, as well as volume of visceral tissue. There is positive 
correlation between L/A ratio and glycaemia at low levels of obesity, when glucose levels in 
blood are still normal, both in men and in women, which might indicate that there is 
significant correlation between the L/A ratio and hyperglycaemia and other disorders of 
glucose metabolism.  
 
Conclusion 
Gender-related differences of the L/A ratio suggest that sex hormones might influence 
body adipose tissue composition and affect certain metabolic parameters. This could be a 
result of sex hormone-induced changes of the mechanisms of adipokine synthesis and 
consequent changes of adipokine activity as signaling factors. Overweight is a warning sign in 
cardiovascular risk assessment as well as a risk factor for development of atherosclerosis. 
Since obesity has ceased to be only a lifestyle consequence and has become a serious disease, 
early detection of risk factors for its development, recognizing the disease in its early stages, 
developing strategies for its prevention and treatment, have become a necessity.  Further 
research in this area is needed, especially of the influence of sex hormones on obesity 
development and influence on metabolic changes. 
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 Figure1. L/A ratio and gender diference in overweight 
 
 
 
